Antithrombotic activity of Desmin 370. Comparison with a high molecular weight dermatan sulfate.
Barbanti
M
M
Istituto di Farmacologia Università di Bologna, Italy.
Calanni
F
F
Babbini
M
M
Bergonzini
G
G
Parma
B
B
Marchi
E
E
Wassermann
A
A
D000818:Animals; D001682:Biological Availability; D003871:Dermatan Sulfate / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D008970:Molecular Weight; D051381:Rats; D017207:Rats, Sprague-Dawley; D013927:Thrombosis / Q000517:prevention & control*; D014682:Vena Cava, Inferior
D005343:Fibrinolytic Agents; D003871:Dermatan Sulfate